Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
New investors often wonder what to ask financial advisors. Discover essential questions that can lead to tailored advice and successful investing.
28,527 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
SpaceX’s highly anticipated IPO faces a major twist as it bars Chinese investors, while Chinese space startups pivot ...
The Department of Justice is considering dropping charges against accused in the BitClub crypto Ponzi scheme, a move ...
Cryptio has closed a $45 million Series B to scale its enterprise crypto accounting platform, aiming to help large fi...
A career setback in 1998 launched Jamie Dimon's rise to the helm of JPMorgan Chase. This piece draws lessons for pers...
A profitability-screened small-cap ETF is gaining attention as markets trend toward earnings power. The fund offers a...
A high-stakes clash between AI safety and national security is unfolding. Anthropic won’t lift safeguards even as the...
Could Lilly ride a Nvidia-like surge? This piece analyzes whether the stock can follow Nvidia’s AI-driven momentum, f...
A new milestone for obesity treatment arrives as Novo Nordisk's Wegovy Pill hits 3 million prescriptions. This articl...
Rocket Lab has been on a volatile ride as the space economy evolves. This guide explains why rocket stock keeps dropp...
AI is reshaping memory demand, and Micron sits at the center. This long-form guide explains the bull case for micron ...
Six non-AI chip makers could be poised to benefit from the AI boom, as demand broadens beyond headline AI chips. Here...